-
New Genomics Pipeline Combines AWS, Local HPC, and Supercomputing
HPCwire | Declining DNA sequencing costs and the rush to do whole genome sequencing (WGS) of large cohort populations presents an infrastructure challenge that some researchers are solving with a hybrid approach.
Sep 23, 2016
-
When “Actionable” Genomic Sequencing Results Cannot Be Acted Upon
JAMA Oncology | Brian J. Zikmund-Fisher recounts an interaction he had with a participant involved in genomic sequencing, in which the term “actionable” led to false hope and dashed expectations.
Sep 23, 2016
-
Gilead Allergan Seen Trailing Intercept In Ongoing NASH Battle
Investor's Business Daily | Gilead is trailing Intercept in the battle against NASH, Credit Suisse analyst Alethia Young said Thursday, two days after Botox maker Allergan jumped in.
Sep 23, 2016
-
Chan Zuckerberg Initiative Lays Out Plan For Funding Disease Research
Bio-IT World | The Chan Zuckerberg Initiative took to Facebook Live yesterday to lay out their plan of funding the Initiative’s first project. The project, a Biohub located in San Francisco, will combine the knowledge of renowned scientists and engineers in the pursuit of curing disease.
Sep 22, 2016
-
Monsanto Licenses CRISPR Technology To Modify Crops
STAT | Agriculture giant Monsanto has licensed CRISPR-Cas9 genome-editing technology from the Broad Institute to develop modified seeds.
Sep 22, 2016
-
Getting Exascale Right, Not First
TOP500 | The path to exascale computing hasn't been an easy one. It has had to face a daunting set of challenges in energy efficiency, application parallelism, and system reliability, just to name a few. The difficulties in bringing the hardware and software up to this level is considerable, but there is a more fundamental challenge at the heart of exascale: doing the necessary work of building an ecosystem that will last for a decade or more, not just for a handful stunt machines.
Sep 21, 2016
-
Taking Care Of Our Own: HR In The Age Of Genomics
Bio-IT World | As far as their employees are concerned, who among these life-science players are putting their money where their mouths are? The search has been on at Bio-IT World for those organizations who are taking the logical step of subsidizing the sequencing their own employees' genomes and the clinical interpretation thereof.
Sep 21, 2016
-
Approving A Muscular Dystrophy Drug Ignites A Civil War At The FDA
Forbes | Yesterday, the Food and Drug Administration made history, approving a drug to treat Duchenne muscular dystrophy that works by targeting the genetic mutation at the root of the disease. The decision was unique for reasons that were not just scientific.
Sep 20, 2016
-
Childhood Cancer Targeted By Sanger Institute And St. Jude Children’s Research Hospital Data-Sharing Agreement
Bio-IT World News Brief | St. Jude's Children's Research Hospital's agreement with the Wellcome Trust Sanger Institute unifies the institute's COSMIC database with the data mining and visualization system of the hospital to better understand the nature of childhood cancers.
Sep 19, 2016
-
Getting Ready For San Diego: Marking Our Agendas For The Converged IT Summit
Bio-IT World | The second annual Converged IT Summit covers an impressive list of speakers expanding the realms of infrastructure and data science. The speakers cover a variety of subjects, such as personalized cardiac therapy, IT for life sciences, and much more.
Sep 19, 2016
-
Oracle is gunning for AWS with new infrastructure offering
Computerworld | Larry Ellison has a message for Amazon Web Services: Oracle will give Amazon a run for its money in the cloud market.
Sep 19, 2016
-
DNA Heist That Wasn’t Sparks Data Questions
Nature News & Comment | Alleged theft from Italian gene bank dismissed - but ownership of samples remains under investigation.
Sep 16, 2016
-
CRISPR Patent Judges Deny Subpoena For Harvard's George Church
STAT | The judges hearing a patent dispute over the discovery of CRISPR genome-editing technology denied a request to subpoena Harvard biologist George Church.
Sep 16, 2016
